Applications Received: 165 (162 reviewed by RAP; 3 reviewed independently (DRC + NORC)) | ||||
Grant Mechanisms | Applications Reviewed | Applications Awarded |
||
# | # | % | ||
1 | CAPS-HIV Innovative Grants | 2 | 1 | 50% |
2 | CORE Operational Improvement Award (COIA-RRP) | 5 | 2 | 40% |
3 | Family Support Award | 1 | 1 | 100% |
4 | Gilead HIV Cure Mentored Scientist Award | 1 | 1 | 100% |
5 | Global Cancer Pilot Award | 2 | 2 | 100% |
6 | Hardship Awards | 4 | 1 | 25% |
7 | Independence Support Award | 3 | 2 | 67% |
8 | Informing Tobacco Product Regulation | 3 | 0 | 0% |
9 | Innovation Award in Prematurity Research | 9 | 0 | 0% |
10 | International Mentored Scientist Award Program in HIV/AIDS | 3 | 1 | 33% |
11 | Mentored Scientist Award Program in HIV/AIDS | 6 | 3 | 50% |
12 | Pilot Award for Investigators New to HIV | 0 | 0 | 0% |
13 | Pilot Award for Pancreas Cancer | 3 | 1 | 33% |
14 | Pilot Award for Prevention and Treatment of Opioid Use Disorders | 6 | 2 | 33% |
15 | Pilot Award for Precision Imaging of Cancer | 2 | 1 | 50% |
16 | Pilot Award in Prematurity Research | 3 | 2 | 67% |
17 | Pilot for Established Investigators | 47 | 13 | 28% |
18 | Pilot for Junior Investigators | 43 | 15 | 35% |
19 | Re-entry | 1 | 0 | 0% |
20 | Shared Technology | 3 | 2 | 67% |
21 | Team Science | 12 | 1 | 8% |
22 | Under-represented Faculty in Clin. and Transl. Research | 3 | 1 | 33% |
TOTALS: | 162 | 52 | 32% | |
128 new submissions; 31 first resubmissions; 3 second resubmissions |
Quicklinks
Grant Deadlines
FALL 2024 CYCLE
Funding Results: will be available via your portal acct. in late December, 2024.
SPRING 2025 CYCLE
Call Opens:Thurs. January 30, 2025
Deadline: Mon. March 3, 2025
(2:00 pm PST)
Funding Results: available before end of May, 2025
TWO CYCLES PER YEAR
SPRING Deadline: February/March
FALL Deadline: September/October